Status:
COMPLETED
Dexmedetomidine Improves the Surgical Field and Postoperative Recovery of Nasal Endoscopic Surgery
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Dexmedetomidine
Bleeding
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Studies showed dexmedetomidine (DEX) could improve surgical field, but the effect for functional nasal endoscopic surgery (FESS) was unclear. The investigators explored IV administration of a single l...
Detailed Description
The participants received an induction of anesthesia with propofol 2-3 mg/kg, sufentanyl 0.2 μg/kg, and rocuronium 0.6 mg/kg, and then insertion of a flexible laryngeal mask airway was conducted using...
Eligibility Criteria
Inclusion
- 120 participants who diagnosed with nasosinusitis
- The participants need undergo functional nasal endoscopic surgery
- The participants signed the informed consent
Exclusion
- The participants were excluded with any diseases about respiration, circulation, liver and kidney
- The participants were rejected of the consent
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2020
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT04276545
Start Date
January 1 2018
End Date
March 10 2020
Last Update
March 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye, Ear, Nose and Throat Hospital
Shanghai, Shanghai Municipality, China, 200031